Pharma News

Eli Lilly has confirmed that Emgality, a once-monthly monoclonal antibody injection, has been approved by the European Commission for preventive treatment of migraine in adults who have at least four ...

There could be hundreds of genes which make people more likely to kill themselves and the trait is believed to run in the family, a study has found.

(Reuters Health) - Most health information data breaches in the U.

(Reuters) - A U.

LONDON (Reuters) - U.

SYDNEY, Nov.

The final research results for a new treatment for protection against accidental exposure to peanut was presented today at the American College of Allergy, Asthma and Immunology (ACAAI) Annual...

Eli Lilly has long been under pressure to replace the revenues it’s losing to generic rivals as former blockbusters such as erectile dysfunction drug Cialis and ADHD drug Strattera face low-cost com...

SAN DIEGO, Nov.

AbbVie’s hepatitis C blockbuster Mavyret could soon also be an eight-week treatment for patients with compensated cirrhosis, thanks to positive new phase 3b data.

Management at Dr.

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion of fexinidazole, the first all-oral treatment that has been ...